NCT06522113View on ClinicalTrials.gov

Cilostazol and Aspirin in Stroke and TIA

PHASE4CompletedINTERVENTIONAL
Enrollment

378

Participants

Timeline

Start Date

July 18, 2019

Primary Completion Date

October 17, 2022

Study Completion Date

October 17, 2022

Conditions
Ischemic StrokeTIA
Interventions
DRUG

Cilostazol

patients were given cilostazol 100mg twice a day with aspirin

DRUG

Clopidogrel

patients were given clopidogrel 75mg with aspirin

Trial Locations (1)

Unknown

The Catholic university of korea, Incheon St. Mary's hospital, Incheon

All Listed Sponsors
lead

Incheon St.Mary's Hospital

OTHER

NCT06522113 - Cilostazol and Aspirin in Stroke and TIA | Biotech Hunter | Biotech Hunter